Senores Pharmaceuticals shares plunge 5% despite 105% YoY surge in...
Mumbai: Senores Pharmaceuticals reported a significant year-on-year surge in its Profit After Tax (PAT) for Q3FY26 increasing 105% to ₹34 crores even as the company’s shares plunged following the news....
